Improving Smoking Cessation Quitlines: Pilot Study of Acceptance Therapy



Status:Completed
Conditions:Smoking Cessation
Therapuetic Areas:Pulmonary / Respiratory Diseases
Healthy:No
Age Range:Any
Updated:9/23/2012
Start Date:March 2012
End Date:September 2013
Contact:Jonathan B. Bricker, Ph.D.
Email:jbricker@fhcrc.org
Phone:206-667-5074

Use our guide to learn which trials are right for you!


The purpose of this study is to demonstrate that Acceptance Therapy (ACT's) implementation
outcomes are at least as good as those of traditional cognitive behavioral therapy (CBT).

Implementation outcomes:

- end of treatment and 6-month follow-up data retention rates;

- intervention implementation quality;

- number & length of calls completed.

Comparison of each arm's implementation


Inclusion Criteria:

1. aged 18 and older;

2. smokes at least 10 cigarettes daily and has done so for at least the past 12 months;

3. wants to quit smoking in the next 30 days;

4. willing to be randomly assigned to either group;

5. willing and able to speak and read in English;

6. willing and medically eligible to use nicotine replacement therapy (NRT),

7. currently resides in the U.S., and expects to continue for at least 12 months;

8. not participating in other smoking cessation interventions;

9. has regular access to a telephone.

10. has regular access to an email address.

Exclusion Criteria:

- The Exclusion criteria are the opposite of the Inclusion criteria listed above. In
addition, the following exclusion criteria also apply:

1. another member of household enrolled in the study;

2. currently using medication or nicotine replacement products to help with
quitting smoking;

3. currently using any non-cigarette tobacco products;

4. pregnant or breastfeeding;

5. had a heart attack in last 30 days;

6. within the last 6 months, diagnosed with angina, heart pain, or irregular
heartbeat;

7. serious adverse reactions to nicotine patches including anaphylaxis and related
symptoms such as hives, respiratory difficulty, and/or angioedema.
We found this trial at
1
site
1100 Fairview Avenue North
Seattle, Washington 98109
(206) 667-5000
Fred Hutchinson Cancer Research Center At Fred Hutchinson Cancer Research Center, our interdisciplinary teams of...
?
mi
from
Seattle, WA
Click here to add this to my saved trials